Samuel Lee Steel, M.D.; Revocation of Registration, 11698-11699 [05-4564]
Download as PDF
<![CDATA[
11698
Federal Register / Vol. 70, No. 45 / Wednesday, March 9, 2005 / Notices
(2004); Prescriptionline.com, 69 FR
5,583 (2004).
In the instant case, Dr. Avello and
other physicians associated with the
Internet scheme, authorized
prescriptions for controlled substances
without the benefit of face-to-face
physician-patient contact, physical
exam or medical tests. Beyond
occasional phone calls to some
customers or their family members,
there is no information in the
investigative file demonstrating that Dr.
Avello and other issuing physicians
associated with Pharmacon even took
time to corroborate response to
questionnaires submitted by the
customers. Here, it is clear the issuance
of controlled substance prescriptions to
persons whom Dr. Avello had not
established a valid physician-patient
relationship is a radical departure from
the normal course of professional
practice and he knowingly participated
in this scheme.
With regard to factor three, Dr.
Avello’s conviction record under
Federal or State laws relating to the
dispensing of controlled substances, the
record does not reflect that he has been
convicted of a crime related to
controlled substances.
Regarding factor five, such other
conduct which may threaten the public
health or safety, the Deputy
Administrator finds this factor relevant
to Dr. Avello’s continued prescribing to
Internet customers after issuance of
policy statements designed to assist
licensed practitioners and pharmacists
in the proper prescribing and
dispensing of dangerous controlled
drugs.
The Deputy Administrator has
previously expressed her deep concern
about the increased risk of diversion
which accompanies Internet controlled
substance transactions. Given the
nascent practice of cyber-distribution of
controlled drugs to faceless individuals,
where interaction between individuals
is limited to information on a computer
screen or credit card, it is virtually
impossible to insure that these highly
addictive, and sometimes dangerous
products will reach the intended
recipient, and if so, whether the person
purchasing these products has an actual
need for them. The ramifications of
obtaining dangerous and highly
addictive drugs with the ease of logging
on to a computer and the use of a credit
card are disturbing and immense,
particularly when one considers the
growing problem of the abuse of
prescription drugs in the United States.
See, EZRX, supra, 69 FR at 63181; Mark
Wade, M.D., supra, 69 FR 7018.
VerDate jul<14>2003
20:21 Mar 08, 2005
Jkt 205001
The Deputy Administrator has also
previously found that in a 2001 report,
the National Clearinghouse for Alcohol
and Drug Information estimated that 4
million Americans ages 12 and older
had acknowledged misusing
prescription drugs. That accounts for
2% to 4% of the population—a rate of
abuse that has quadrupled since 1980.
Prescription drug abuse—typically of
painkillers, sedatives and mood altering
drugs—accounts for one-third of all
illicit drug use in the United States. See
EZRX, supra, 69 FR at 63181–82, Mark
Wade, M.D., supra, 679 FR 7018.
The Deputy Administrator finds that
with respect to Internet transactions
involving controlled substances, the
horrific untold stories of drug abuse,
addiction and treatment are the
unintended, but foreseeable
consequence of providing highly
addictive drugs to the public without
oversight. The closed system of
distribution, brought about by the
enactment of the Controlled Substances
Act, is completely compromised when
individuals can easily acquire
controlled substances without regard to
age or health status. Such lack of
oversight describes Dr. Avello’s practice
of issuing prescriptions for controlled
substances to indistinct Internet
customers which are then filled by
pharmacies participating in the scheme.
Such conduct contributes to the abuse
of controlled substances by Dr. Avello
and Pharmacon’s customers and is
relevant under factor five, further
supporting revocation of his DEA
Certificate of Registration.
Motivated purely by profit and in
pursuit of financial gain, Dr. Avello has
demonstrated a cavalier disregard for
controlled substance laws and
regulations and a disturbing
indifference to the health and safety of
individuals who purchased dangerous
drugs through the Internet. Such
demonstrated lack of character and
adherence to the responsibilities
inherent in a DEA registration show in
no uncertain terms that Dr. Avello’s
continued registration with DEA would
be inconsistent with the public interest.
Accordingly, the Deputy
Administrator of the Drug Enforcement
Administration, pursuant to the
authority vested in her by 21 U.S.C. 823
and 824 and 28 CFR 0.100(b) and 0.104,
hereby orders that DEA Certificate of
Registration AA0105747, issued to
Mario Avello, M.D., be, and is hereby is,
revoked. The Deputy Administrator
further orders that any pending
applications for renewal of such
registration be, and they hereby are
denied. This order is effective April 8,
2005.
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
Dated: January 14, 2005.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. 05–4563 Filed 3–8–05; 8:45 am]
BILLING CODE 4410–09–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Samuel Lee Steel, M.D.; Revocation of
Registration
On August 20, 2004, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to Samuel Lee Steel,
M.D. (Dr. Steel) who was notified of an
opportunity to show cause as to why
DEA should not revoke his DEA
Certificate of Registration BS5024865,
pursuant to 21 U.S.C. 824(a)(3) and
deny any pending applications under 21
U.S.C. 823(f), on the ground that he
lacked state authority to handle
controlled substances in the State of
California. The Order to Show Cause
also notified Dr. Steel that should no
request for a hearing be filed with 30
days, his hearing right would be deemed
waived.
The order to Show Cause was sent by
certified mail to Dr. Steel at his
registered address of 1150 North Canyon
Drive, Palm Springs, California 92263.
According to the return receipt of the
Order, it was accepted on Dr. Steel’s
behalf on September 1, 2004. DEA has
not received a request for hearing or any
other reply from Dr. Steel or anyone
purporting to represent him in this
matter.
Therefore, the Deputy Administrator
of DEA, finding that (1) thirty days
having passed since the delivery of the
Order to Show Cause to the registrant’s
address of record and (2) no request for
hearing having been received, concludes
that Dr. Steel is deemed to have waived
his hearing right. See David W. Linder,
67 FR 12579 (2002). After considering
material from the investigative file in
this matter, the Deputy Administrator
now enters her final order without a
hearing pursuant to 21 CFR 1301.43(d)
and (e) and 1301.46.
The Deputy Administrator finds that
Dr. Steel is currently registered with
DEA as a practitioner authorized to
handle controlled substances in
Schedules II through V under Certificate
of Registration BS5024865, expiring on
February 29, 2005. According to
information in the investigative file,
following an Interim Order of
Suspension, on April 1, 2004, the
Medical Board of California (Board)
E:\FR\FM\09MRN1.SGM
09MRN1
Federal Register / Vol. 70, No. 45 / Wednesday, March 9, 2005 / Notices
revoked Dr. Steel’s Physician and
Surgeon’s Certificate, effective as of May
3, 2004. The revocation was based on
the Board’s finding that Dr. Steel was
mentally impaired to a degree that he
was unable to safely practice medicine.
There is no evidence before the
Deputy Administrator to rebut a finding
that Dr. Steel’s California medical
license has been revoked. Therefore, the
Deputy Administrator finds Dr. Steel is
currently not authorized to practice
medicine in the State of California. As
a result, it is reasonable to infer that he
is also without authorization to handle
controlled substances in that State.
DEA does not have statutory authority
under the Controlled Substance Act to
issue or maintain a registration if the
applicant or registrant is without state
authority to handle controlled
substances in the state in which he
conducts business. See 21 U.S.C.
802(21), 823(f) and 824(a)(3). This
prerequisite has been consistently
upheld. See Richard J. Clement, M.D.,
68 FR 12103 (2003); Dominick A. Ricci,
M.D., 68 FR 51104 (1993); Bobby Watts,
M.D., 53 FR 11919 (1988).
Here, it is clear that Dr. Steel’s state
medical license was revoked after being
initially suspended and there is no
information before the Deputy
Administrator which points to that
revocation having been lifted or stayed.
As a result, Dr. Steel is not authorized
to practice medicine or handle
controlled substances in California,
where he is registered with DEA.
Therefore, he is not entitled to maintain
that registration.
Accordingly, the Deputy
Administrator of the Drug Enforcement
Administration, pursuant to the
authority vested in her by 21 U.S.C. 823
and 824 and 28 CFR 0.100(b) and 0.104,
hereby orders that DEA Certificate of
Registration, BS5024865, issued to
Samuel Lee Steel, M.D., be, and it
hereby is, revoked. The Deputy
Administrator further orders that any
pending applications for renewal or
modification of the aforementioned
registration be, and hereby are, denied.
This order is effective April 8, 2005.
Dated: January 14, 2005.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. 05–4564 Filed 3–8–05; 8:45 am]
BILLING CODE 4410–09–M
VerDate jul<14>2003
18:06 Mar 08, 2005
Jkt 205001
DEPARTMENT OF LABOR
Employee Benefits Security
Administration
Proposed Extension of Information
Collection Request Submitted for
Public Comment; Consent To Receive
Employee Benefit Plan Disclosure
Electronically
Employee Benefits Security
Administration, Department of Labor.
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a preclearance consultation
program to provide the general public
and Federal agencies with an
opportunity to comment on proposed
and continuing collections of
information in accordance with the
Paperwork Reduction Act of 1995 (PRA
95). This program helps to ensure that
requested data can be provided in the
desired format, reporting burden (time
and financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. Currently, the
Employee Benefits Security
Administration is soliciting comments
on the proposed extension of an
information collection request (ICR)
incorporated in the Final Rules relating
to the use of electronic communication
and recordkeeping technologies by
employee pension and welfare benefit
plans (29 CFR 2520.104b–1).
A copy of the information collection
request (ICR) can be obtained by
contacting the individual shown in the
ADDRESSES section of this notice.
DATES: Written comments must be
submitted to the office shown in the
Addresses section on or before May 9,
2005.
ADDRESSES: Gerald B. Lindrew,
Department of Labor, Employee Benefits
Security Administration, 200
Constitution Avenue NW., Washington,
DC 20210, (202) 693–8410, Fax (202)
693–4745 (these are not toll-free
numbers).
SUPPLEMENTARY INFORMATION:
I. Background
The Department established a safe
harbor pursuant to which all pension
and welfare benefit plans covered by
Title I of ERISA may use electronic
media to satisfy disclosure obligations
under Title I of ERISA (29 CFR
2520.104b–1). Employee benefit plan
administrators will be deemed to satisfy
their disclosure obligations when
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
11699
furnishing documents electronically
only if a participant who does not have
access to the employer’s electronic
information system in the normal course
of his duties, or a beneficiary or other
person entitled to documents, has
affirmatively consented to receive
disclosure documents. Prior to
consenting, the participant or
beneficiary must also be provided with
a clear and conspicuous statement
indicating the types of documents to
which the consent would apply, that
consent may be withdrawn at any time,
procedures for withdrawing consent and
updating necessary information, the
right to obtain a paper copy, and any
hardware and software requirements. In
the event of a hardware or software
change that creates a material risk that
the individual will be unable to access
or retain documents that were the
subject of the initial consent, the
individual must be provided with
information concerning the revised
hardware or software, and an
opportunity to withdraw a prior
consent.
II. Review Focus
The Department of Labor
(Department) is particularly interested
in comments that:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
III. Current Actions
The Office of Management and
Budget’s (OMB) approval of this ICR
will expire on May 31, 2005. After
considering comments received in
response to this notice, the Department
intends to submit the ICR to OMB for
continuing approval. No change to the
existing ICR is proposed or made at this
time.
Comments submitted in response to
this notice will be summarized and/or
E:\FR\FM\09MRN1.SGM
09MRN1
]]>Agencies
[Federal Register Volume 70, Number 45 (Wednesday, March 9, 2005)]
[Notices]
[Pages 11698-11699]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4564]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Samuel Lee Steel, M.D.; Revocation of Registration
On August 20, 2004, the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration (DEA), issued an
Order to Show Cause to Samuel Lee Steel, M.D. (Dr. Steel) who was
notified of an opportunity to show cause as to why DEA should not
revoke his DEA Certificate of Registration BS5024865, pursuant to 21
U.S.C. 824(a)(3) and deny any pending applications under 21 U.S.C.
823(f), on the ground that he lacked state authority to handle
controlled substances in the State of California. The Order to Show
Cause also notified Dr. Steel that should no request for a hearing be
filed with 30 days, his hearing right would be deemed waived.
The order to Show Cause was sent by certified mail to Dr. Steel at
his registered address of 1150 North Canyon Drive, Palm Springs,
California 92263. According to the return receipt of the Order, it was
accepted on Dr. Steel's behalf on September 1, 2004. DEA has not
received a request for hearing or any other reply from Dr. Steel or
anyone purporting to represent him in this matter.
Therefore, the Deputy Administrator of DEA, finding that (1) thirty
days having passed since the delivery of the Order to Show Cause to the
registrant's address of record and (2) no request for hearing having
been received, concludes that Dr. Steel is deemed to have waived his
hearing right. See David W. Linder, 67 FR 12579 (2002). After
considering material from the investigative file in this matter, the
Deputy Administrator now enters her final order without a hearing
pursuant to 21 CFR 1301.43(d) and (e) and 1301.46.
The Deputy Administrator finds that Dr. Steel is currently
registered with DEA as a practitioner authorized to handle controlled
substances in Schedules II through V under Certificate of Registration
BS5024865, expiring on February 29, 2005. According to information in
the investigative file, following an Interim Order of Suspension, on
April 1, 2004, the Medical Board of California (Board)
[[Page 11699]]
revoked Dr. Steel's Physician and Surgeon's Certificate, effective as
of May 3, 2004. The revocation was based on the Board's finding that
Dr. Steel was mentally impaired to a degree that he was unable to
safely practice medicine.
There is no evidence before the Deputy Administrator to rebut a
finding that Dr. Steel's California medical license has been revoked.
Therefore, the Deputy Administrator finds Dr. Steel is currently not
authorized to practice medicine in the State of California. As a
result, it is reasonable to infer that he is also without authorization
to handle controlled substances in that State.
DEA does not have statutory authority under the Controlled
Substance Act to issue or maintain a registration if the applicant or
registrant is without state authority to handle controlled substances
in the state in which he conducts business. See 21 U.S.C. 802(21),
823(f) and 824(a)(3). This prerequisite has been consistently upheld.
See Richard J. Clement, M.D., 68 FR 12103 (2003); Dominick A. Ricci,
M.D., 68 FR 51104 (1993); Bobby Watts, M.D., 53 FR 11919 (1988).
Here, it is clear that Dr. Steel's state medical license was
revoked after being initially suspended and there is no information
before the Deputy Administrator which points to that revocation having
been lifted or stayed. As a result, Dr. Steel is not authorized to
practice medicine or handle controlled substances in California, where
he is registered with DEA. Therefore, he is not entitled to maintain
that registration.
Accordingly, the Deputy Administrator of the Drug Enforcement
Administration, pursuant to the authority vested in her by 21 U.S.C.
823 and 824 and 28 CFR 0.100(b) and 0.104, hereby orders that DEA
Certificate of Registration, BS5024865, issued to Samuel Lee Steel,
M.D., be, and it hereby is, revoked. The Deputy Administrator further
orders that any pending applications for renewal or modification of the
aforementioned registration be, and hereby are, denied. This order is
effective April 8, 2005.
Dated: January 14, 2005.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. 05-4564 Filed 3-8-05; 8:45 am]
BILLING CODE 4410-09-M
